We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App




Saliva Test Identifies Healthy Older People with Cognitive Problems

By LabMedica International staff writers
Posted on 15 Sep 2015
The saliva of healthy older people should be tested for the level of the stress hormone cortisol and this may help identify individuals who should be screened for problems with thinking skills.

The association between morning and evening salivary cortisol levels and regional brain volumes in older persons without dementia and the relationship with cognitive functioning to determine the potential clinical relevance of observed differences in brain volume has been investigated. More...


Scientists from the US National Institute on Aging (Bethesda, MD, USA) and their colleagues studied 4,244 persons without dementia whose mean age was 76 ± 5 years, and 58% were women. All enrollees had a brain magnetic resonance imaging (MRI) scan, and assessment of cognitive functioning. Saliva samples were taken from the participants once in the morning and in the evening to determine cortisol levels. Participants were divided into three groups based on cortisol levels of high, medium, and low.

Saliva samples were collected with the Salivette collection device (Sarstedt; Rommelsdorf, Germany). Salivary cortisol was analyzed with a Delfia time-resolved immunoassay with fluorescence detection (PerkinElmer; Waltham, MA, USA). The lower detection limit was 0.43 nmol/L for a 50-mL salivary sample. Morning or evening cortisol values of greater than 100 nmol/L were considered unreliable and excluded, but this was only 0.7% of morning samples and 0.5% of evening samples. Dementia ascertainment was a three-step protocol and a battery of six different cognitive tests was administered to all participants.

In the 4,244 participants, the mean morning cortisol level was 20 ±13.5 nmol/L and the median evening cortisol level was 2.3 nmol/L. People with the highest level of cortisol were more likely to have a smaller overall brain volume than those with lower levels of cortisol. Those with the highest level of cortisol also performed worse on the memory and thinking tests than those with low levels of the hormone. Poorer cognitive functioning across all domains was also associated with higher evening cortisol. Higher levels of morning cortisol were associated with slightly greater normal white matter volume and better processing speed and executive functioning, but not with gray matter volume or with memory performance.

Lenore J. Launer, PhD, the senior author of the study said, “Since this study just looked at a snapshot in time, we don’t know which came first: the high levels of cortisol or the loss of brain volume. It’s possible that the loss of brain volume that can occur with aging leads to a lesser ability of the brain to stop the effects of cortisol, which in turn leads to further loss of brain cells. Understanding these relationships may help us develop strategies to reduce the effects of cortisol on the brain and thinking skills.” The study was published on August 19, 2015, in the journal Neurology.

Related Links:
US National Institute on Aging 
Sarstedt 
PerkinElmer 



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.